Baltimore, MD, United States of America

Reiko Takasaka Lee

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Institute of Nuclear Energy Research, Johns Hopkins University. Active years: 2013-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reiko Takasaka Lee. Retrieved from https://idiyas.com/inventor/reiko-takasaka-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 81(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Reiko Takasaka Lee: Innovator in Liver Function Quantification

Introduction

Reiko Takasaka Lee is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of liver function quantification through her innovative patents. With a total of 3 patents, her work focuses on improving clinical outcomes for patients with liver diseases.

Latest Patents

One of her latest patents is a quantification method for remaining liver function and a novel liver receptor imaging agent. This invention provides a test indicator for quantifying remaining liver function, which is crucial for assessing liver failure outcomes in clinical settings. The method utilizes a liver receptor imaging agent that targets the liver, helping to determine the necessity of liver transplantation for patients suffering from liver failure or disease. The radioactivity uptake of the test indicator is negatively correlated with the extent of liver reserve, and the patent also discloses a cutoff value for liver transplantation.

Another significant patent involves liver-targeting agents and their synthesis. This invention presents novel liver targeting agents with a lysine-based nitrilotriacetic acid structure that acquires multivalency with saccharide groups. The agent is designed to bind with a galactosamine chain or lactose chain, utilizing only one amino acid, L-lysine, to provide trivalency. The invention also details methods for synthesizing these agents, including the conjugation of multiple glycosides in a single step.

Career Highlights

Reiko has worked with esteemed organizations such as the Institute of Nuclear Energy Research and the Johns Hopkins University. Her experience in these institutions has allowed her to develop groundbreaking technologies that enhance liver function assessment.

Collaborations

Throughout her career, Reiko has collaborated with notable colleagues, including Yuan-Chuan Lee and Mei-Hui Wang. These partnerships have contributed to her innovative research and development efforts.

Conclusion

Reiko Takasaka Lee's contributions to liver function quantification through her patents demonstrate her commitment to advancing medical technology. Her work not only enhances clinical practices but also improves patient outcomes in liver disease management.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…